-64.0%
ENPH vs SBAC
-6.8%
-57.2%
-81.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | SBAC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +2.4% | -0.7% | +3.1% | +2.6% |
| 7D | -10.3% | -2.8% | -7.5% | -9.6% |
| 30D | -10.1% | +3.1% | -13.3% | -10.9% |
| 3M | -33.1% | +5.1% | -38.2% | -34.1% |
| 6M | -24.8% | -11.4% | -13.4% | -22.6% |
| YTD | -11.7% | +0.2% | -11.9% | -14.6% |
| 1Y | -8.2% | -3.9% | -4.3% | -8.7% |
| All | -64.0% | -6.8% | -57.2% | -63.1% |
Cumulative growth
Daily Returns
Daily percentage return beside SBAC.
Daily Out/Under-Performance
Portfolio return minus SBAC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SBAC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded SBAC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling